Logzy beside agreeing with you below the last announcement from...

Logzy beside agreeing with you below the last announcement from Diamond:

"Antisense Therapeutics (“ANP” or the “Company”) has initiated the process for submission of the ATL1102 for Multiple Sclerosis (MS) Phase IIb IND application with documentation being provided to its Regulatory Agent in the US who, on the Company’s behalf, will submit the IND application to the US Food and Drug Administration (FDA). This submission process is expected to be completed in May. Following the IND submission, the Company must wait 30 calendar days for the FDA review. "

The emphasis should be on:
"This submission process is expected to be completed in May"
I assume Diamond meant May 2017. Since this is the last week in May I get the feeling we will receive
a new buy-time misleading announcement, if any, or something totally different just to try to redirect
shareholder attention to some other subject. As said before the best announcement we can hope would be
one starting with: " I hereby tender my resignation.......etc etc "
Have a good day fellow s.holders